kneat.com (TSE:KSI) Given a C$6.00 Price Target by CIBC Analysts

kneat.com (TSE:KSI) has been given a C$6.00 price objective by stock analysts at CIBC in a research report issued to clients and investors on Tuesday, BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. CIBC’s price target would indicate a potential upside of 25.00% from the company’s current price.

Separately, Ventum Cap Mkts raised kneat.com to a “strong-buy” rating in a research note on Wednesday, August 7th.

kneat.com Price Performance

TSE:KSI opened at C$4.80 on Tuesday. kneat.com has a one year low of C$2.68 and a one year high of C$5.17. The company has a debt-to-equity ratio of 95.14, a quick ratio of 1.50 and a current ratio of 1.47. The stock has a market cap of C$412.80 million, a PE ratio of -30.00, a P/E/G ratio of 597.67 and a beta of 1.08. The stock has a 50 day moving average price of C$4.76 and a 200 day moving average price of C$4.44.

kneat.com (TSE:KSI) last posted its quarterly earnings results on Tuesday, August 6th. The company reported C($0.04) EPS for the quarter, meeting the consensus estimate of C($0.04). The firm had revenue of C$11.68 million during the quarter, compared to analysts’ expectations of C$11.45 million. kneat.com had a negative return on equity of 51.13% and a negative net margin of 31.19%. Equities research analysts expect that kneat.com will post -0.12 EPS for the current fiscal year.

kneat.com Company Profile

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.